ChristopherBBentonMD

PubMed

• 9 citations
  Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
  Christopher B. Benton, Kelly S. Chien, Ayalew Tefferi, Jose A. Rodriguez, Farhad Ravandi, Naval Daver, Elias Jabbour, Nitin Jain, Yesid Alvarado, Monica Kwari, Sherry ...> ;Hematological Oncology. 2019 Feb 1
• 62 citations
  Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial
  Tapan M. Kadia, Jorge E. Cortes, Farhad Ravandi, Elias Jabbour, Marina Konopleva, Christopher B. Benton, Jan A. Burger, Koji Sasaki, Gautam Borthakur, Courtney D. DiNa...> ;The Lancet. Haematology. 2018 Sep 1
• 29 citations
  Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R
  Christopher B. Benton, Maliha Khan, David A. Sallman, Aziz Nazha, Graciela M. Nogueras González, Jin Piao, Jing Ning, Fleur M. Aung, Najla Al Ali, Elias Jabbour, Tapan...> ;American Journal of Hematology. 2018 Oct 1
• 23 citations
  Influence of IDH on FLT3-ITD status in newly diagnosed AML.
  Prajwal Boddu, Koichi Takahashi, Naveen Pemmaraju, Naval Daver, Christopher B. Benton, Sherry Pierce, Marina Konopleva, Farhad Ravandi, Jorge E. Cortes, Hagop M. Kanta...> ;Leukemia. 2017 Jul 28
• Join now to see all